What component of breastmilk (breast milk) can cause jaundice?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 15, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

What Component of Breastmilk Causes Jaundice

The specific component in breast milk that causes breast milk jaundice remains unidentified, though research confirms that an unknown factor in the milk of a small percentage of mothers increases enterohepatic circulation of bilirubin, leading to prolonged unconjugated hyperbilirubinemia. 1, 2

The Unidentified Culprit

Despite decades of research, the exact substance responsible for breast milk jaundice has not been definitively identified:

  • An as-yet unidentified factor exists in the human milk of a small minority of women (1-2% of breastfeeding mothers) that inhibits bilirubin clearance and increases enterohepatic circulation 1, 3
  • This unknown component triggers jaundice particularly in infants who have underlying genetic mutations in the bilirubin uridine diphosphate-glucuronosyltransferase gene (UGT1A1), the same mutations found in Gilbert's syndrome 2
  • The factor works by enhancing the recycling of bilirubin through the enterohepatic circulation rather than through direct hepatotoxicity 1, 4

Critical Distinction: Two Different Mechanisms

It's essential to differentiate between two types of jaundice in breastfed infants, as they have different causes:

Breastfeeding Jaundice (Early-Onset)

  • Caused by inadequate caloric intake and dehydration, not by a milk component 5, 4
  • Occurs in the first week of life when feeding frequency is insufficient (fewer than 8-12 times per day) 6, 5
  • This represents "starvation jaundice" due to poor feeding technique, not a breast milk factor 4

Breast Milk Jaundice (Late-Onset)

  • Caused by the unidentified factor in breast milk itself 1, 2
  • Appears later (typically after the first week), peaks around week 2-3, and can persist until weeks 7-13 3
  • Occurs even with adequate feeding and hydration 1

Genetic Susceptibility

The severity of breast milk jaundice appears related to infant genetics rather than variation in the milk component:

  • 16 of 17 infants with prolonged breast milk jaundice had mutations in the UGT1A1 gene, with the G71R mutation being most common in Japanese populations 2
  • These mutations reduce bilirubin conjugation enzyme activity to approximately one-third of normal 2
  • The breast milk factor acts as a trigger in genetically susceptible infants rather than causing jaundice in all exposed infants 2

Clinical Implications

Breastfeeding should continue without interruption in most cases of breast milk jaundice, as the condition is benign and self-limited 5, 7

  • Temporary interruption is only considered if bilirubin exceeds 270 μmol/L (approximately 16 mg/dL) and continues rising, or if phototherapy becomes necessary 5
  • The benefits of continued breastfeeding—including reduced infections, enhanced organ maturity, and potential tissue protection—outweigh the risks of mild to moderate hyperbilirubinemia 8
  • Colostrum and frequent feeding (8-12 times per 24 hours) increase stooling, which actually helps prevent pathologic hyperbilirubinemia by reducing enterohepatic circulation 9, 7

Common Pitfall to Avoid

Do not assume all jaundice in breastfed infants is benign breast milk jaundice. Always measure bilirubin levels, exclude pathologic causes (hemolysis, G6PD deficiency, hypothyroidism), and optimize breastfeeding technique before attributing jaundice solely to breast milk 5, 7

References

Research

Breastfeeding and jaundice.

Journal of perinatology : official journal of the California Perinatal Association, 2001

Guideline

Differentiating Breastfeeding Jaundice from Breast Milk Jaundice

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Management of Indirect Hyperbilirubinemia in Term Infants

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Breast Milk and Infant Stool Patterns

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.